Caregiver support at different stages of Alzheimer's disease
Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
This project uses questionnaires to see how family caregivers help people aged 60 and older with Alzheimer's disease at different stages and what that care costs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 312 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Villeurbanne) |
| Trial ID | NCT07409506 on ClinicalTrials.gov |
What this trial studies
This observational study enrolls patients from the MEM-AURA cohort at Hôpital des Charpennes and their caregivers and uses the RUD (Resource Utilization in Dementia) questionnaire to record informal care activities and time. Eligible patients are community-dwelling adults with clinically probable Alzheimer's disease and an MMSE score ≤ 26 who attend with a caregiver, while those in institutions or under legal protection are excluded. Collected data will quantify caregiver time, tasks, and the economic value of informal care across disease stages to estimate the burden in a French setting. The results aim to inform healthcare planning and support services for families managing Alzheimer's disease at home.
Who should consider this trial
Good fit: Ideal participants are community-dwelling adults aged 60 or older with clinically probable Alzheimer's disease (MMSE ≤ 26) from the MEM-AURA cohort who are accompanied by an informal caregiver.
Not a fit: People living in nursing homes, those without an accompanying informal caregiver, or those under legal protection are not included and are unlikely to benefit from this study's findings.
Why it matters
Potential benefit: If successful, the findings could help shape policies and services that better support caregivers and help people with Alzheimer's remain at home longer.
How similar studies have performed: Previous observational studies using the RUD and similar instruments have repeatedly documented substantial informal care time and costs, so the methods are established though local estimates vary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients from Charpennes Hospital included in the MEM-AURA cohort * Patients aged 60 years and older at inclusion * Patients with dementia due to clinically probable Alzheimer's disease, regardless of stage * Patients with a Mini-Mental State Evaluation (MMSE) score ≤ 26 at inclusion * Patients accompanied by a caregiver at inclusion Exclusion Criteria: * \- Patients or caregivers who have expressed their opposition to the study * Patients living in institutions or nursing homes * Patients protected by law (under legal protection, guardianship, or conservatorship) Early termination Criteria : \- Patients or caregivers withdrawing their consent to participate during the study
Where this trial is running
Villeurbanne
- Hôpital des Charpennes — Villeurbanne, France (Recruiting)
Study contacts
- Study coordinator: GERVAIS F M Frédéric GERVAIS
- Email: frederic.gervais02@chu-lyon.fr
- Phone: 0033 4 72 43 20 66
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.